152 related articles for article (PubMed ID: 31807947)
1. Mannose-Modified PLGA Nanoparticles for Sustained and Targeted Delivery in Hepatitis B Virus Immunoprophylaxis.
Zhu J; Qin F; Ji Z; Fei W; Tan Z; Hu Y; Zheng C
AAPS PharmSciTech; 2019 Dec; 21(1):13. PubMed ID: 31807947
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
3. Dissolving Microneedle Arrays as a Hepatitis B Vaccine Delivery System Adjuvanted by APC-Targeted Poly (Lactic-co-Glycolic Acid) (PLGA) Nanoparticles.
Zheng X; Zhu J; Zheng C; Tan Z; Ji Z; Tao J; Zhao Y; Ji Z; Hu Y
AAPS PharmSciTech; 2023 Jan; 24(1):42. PubMed ID: 36697935
[TBL] [Abstract][Full Text] [Related]
4. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
[TBL] [Abstract][Full Text] [Related]
5. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
6. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route.
Mishra H; Mishra D; Mishra PK; Nahar M; Dubey V; Jain NK
J Pharm Pharm Sci; 2010; 13(4):495-509. PubMed ID: 21486527
[TBL] [Abstract][Full Text] [Related]
9. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.
Zhang Y; Gu P; Wusiman A; Xu S; Ni H; Qiu T; Liu Z; Hu Y; Liu J; Wang D
Int J Nanomedicine; 2020; 15():5527-5543. PubMed ID: 32848386
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
[TBL] [Abstract][Full Text] [Related]
11. APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine.
Layek B; Lipp L; Singh J
J Control Release; 2015 Jun; 207():143-53. PubMed ID: 25886704
[TBL] [Abstract][Full Text] [Related]
12. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
13. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
[TBL] [Abstract][Full Text] [Related]
14. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B.
Gupta PN; Khatri K; Goyal AK; Mishra N; Vyas SP
J Drug Target; 2007 Dec; 15(10):701-13. PubMed ID: 18041638
[TBL] [Abstract][Full Text] [Related]
15. Novel nanoparticles for the delivery of recombinant hepatitis B vaccine.
Bharali DJ; Pradhan V; Elkin G; Qi W; Hutson A; Mousa SA; Thanavala Y
Nanomedicine; 2008 Dec; 4(4):311-7. PubMed ID: 18640075
[TBL] [Abstract][Full Text] [Related]
16. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers.
Dewangan HK; Pandey T; Maurya L; Singh S
Int J Biol Macromol; 2018 May; 111():804-812. PubMed ID: 29343454
[TBL] [Abstract][Full Text] [Related]
17. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
Thomas C; Rawat A; Hope-Weeks L; Ahsan F
Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
[TBL] [Abstract][Full Text] [Related]
18. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
19. HBs antigen and mannose loading on the surface of iron oxide nanoparticles in order to immuno-targeting: fabrication, characterization, cellular and humoral immunoassay.
Rezaei M; Hosseini SN; Khavari-Nejad RA; Najafi F; Mahdavi M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1543-1558. PubMed ID: 31007088
[TBL] [Abstract][Full Text] [Related]
20. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.
He XW; Wang F; Jiang L; Li J; Liu SK; Xiao ZY; Jin XQ; Zhang YN; He Y; Li K; Guo YJ; Sun SH
J Gen Virol; 2005 Mar; 86(Pt 3):601-610. PubMed ID: 15722520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
